Workshop: “DNA Methylation, Understanding the “Epigenetic Clock”, Reversing “Warburg Cellular Changes” and DNA Methylation. A New Paradign in Understanding Aging, Cancer Prevention, Early Diagnosis of Cancer and Its Treatment.”
Background: Published statistics currently reveal that 50-year-old humans have a 50% lifetime incidence of cancer. Once humans turn age 65, that lifetime cancer risk is known to be 68%. Current medical practices ignore this risk, cannot address this risk, or are unable to address this risk responsibly. Practitioners continue to use outdated cancer screening methods that cannot diagnose cancer until it is systemic disease (two exceptions are possibly, Pap Smears and Colonoscopy, as these can detect precancerous cells or polyps and removal of these cells or polyps can be preventative). Many practitioners and patients continue to employ anecdotal cancer prevention regimens that have no reliable evidence of effectiveness. The IvyGene test can be used to assess these regimens.
Methods: This presentation will discuss using the IvyGene test to detect DNA methylation at levels which correlate with over 95% reliability, over 90% sensitivity, and less than 0.5% false negative rate, with cancer cell presence. Based on average cancer cell doubling times, this test can be used to diagnose cancer up to 8.5 years before any radiologic test could possibly detect the disease in some cases. Since DNA methylation correlates with aging, the significance of the utilization of this test in determining the presence of disease is profound. Over 200 patients have been screened and followed for up to two years duration.
-To learn about DNA methylation significance and its relation to the disease of cancer and its relationship to the “Epigenetic Clock” according to Dr. Steve Horvath.
-To learn about cellular Mitochondrial and physiologic changes according to Dr. Warburg, Dr. Thomas Seyfried, and others that contribute to cancer cell physiologic changes and their known specific pathways and causes including iron and Ascorbic acid.
-To review the use of biomarkers in cancer detection and treatment of microscopic or persistent disease.
-To learn about natural food derived supplements that can have significant effects on the development and progress of cancer physiology and the speed of aging.
-To show what supplements can actively help deter cancer’s progression when used within a specific therapeutic approach.